Lexaria Bioscience Corp (LEXX)
2.19
-0.01
(-0.45%)
USD |
NASDAQ |
Apr 25, 16:00
2.20
+0.01
(+0.46%)
After-Hours: 20:00
Lexaria Bioscience Total Liabilities (Quarterly): 0.2042M for Feb. 29, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | 0.2042M |
| November 30, 2023 | 0.254M |
| August 31, 2023 | 0.4039M |
| May 31, 2023 | 1.198M |
| February 28, 2023 | 0.2231M |
| November 30, 2022 | 0.2815M |
| August 31, 2022 | 0.2014M |
| May 31, 2022 | 0.2252M |
| February 28, 2022 | 0.1946M |
| November 30, 2021 | 0.2773M |
| August 31, 2021 | 0.2033M |
| May 31, 2021 | 0.2814M |
| February 28, 2021 | 0.4695M |
| November 30, 2020 | 0.3533M |
| August 31, 2020 | 0.346M |
| May 31, 2020 | 0.1197M |
| February 29, 2020 | 0.0633M |
| November 30, 2019 | 0.1302M |
| August 31, 2019 | 0.1845M |
| May 31, 2019 | 0.1323M |
| February 28, 2019 | 0.5001M |
| November 30, 2018 | 0.1299M |
| August 31, 2018 | 0.0436M |
| May 31, 2018 | 0.0716M |
| February 28, 2018 | 0.069M |
| Date | Value |
|---|---|
| November 30, 2017 | 0.0957M |
| August 31, 2017 | 0.0923M |
| May 31, 2017 | 0.085M |
| February 28, 2017 | 0.3785M |
| November 30, 2016 | 0.5135M |
| August 31, 2016 | 0.4789M |
| May 31, 2016 | 0.3765M |
| February 29, 2016 | 0.2843M |
| November 30, 2015 | 0.1774M |
| August 31, 2015 | 0.0551M |
| May 31, 2015 | 0.0626M |
| February 28, 2015 | 0.0381M |
| November 30, 2014 | 0.7894M |
| July 31, 2014 | 1.017M |
| April 30, 2014 | 1.105M |
| January 31, 2014 | 1.532M |
| October 31, 2013 | 1.474M |
| July 31, 2013 | 1.458M |
| April 30, 2013 | 1.538M |
| January 31, 2013 | 1.614M |
| October 31, 2012 | 1.771M |
| July 31, 2012 | 1.836M |
| April 30, 2012 | 1.811M |
| January 31, 2012 | 1.676M |
| October 31, 2011 | 1.678M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.0633M
Minimum
Feb 2020
1.198M
Maximum
May 2023
0.2874M
Average
0.2241M
Median
Total Liabilities (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 170.11M |
| Sunshine Biopharma Inc | 6.140M |
| Acasti Pharma Inc | 11.50M |
| Edesa Biotech Inc | 1.987M |
| Xenon Pharmaceuticals Inc | 36.88M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.352M |
| Shareholders Equity (Quarterly) | 6.521M |
| Current Ratio | 66.29 |